LEN-B vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Lennar Corporation exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and an exceptionally clean balance sheet (Debt/Equity 0.25). While the stock is significantly undervalued relative to its Graham Number ($117.86), it is currently plagued by severe fundamental deterioration, with earnings plummeting over 50% YoY. The disconnect between strong solvency and crashing growth, coupled with a 0/100 technical trend, suggests a value trap scenario in the short term despite long-term defensive viability.
Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.
Compare Another Pair
Related Comparisons
LEN-B vs TSLA: Head-to-Head Comparison
This page compares Lennar Corporation (LEN-B) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.